These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 12908448)

  • 1. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells.
    Lowe L; Hansen CM; Senaratne S; Colston KW
    Recent Results Cancer Res; 2003; 164():99-110. PubMed ID: 12908448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.
    Colston KW; Hansen CM
    Endocr Relat Cancer; 2002 Mar; 9(1):45-59. PubMed ID: 11914182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY; Mackay AG; Colston KW
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ; Welsh J
    Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.
    Colston KW; Chander SK; Mackay AG; Coombes RC
    Biochem Pharmacol; 1992 Aug; 44(4):693-702. PubMed ID: 1324683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
    Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis.
    Vandewalle B; Hornez L; Wattez N; Revillion F; Lefebvre J
    Int J Cancer; 1995 Jun; 61(6):806-11. PubMed ID: 7790115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs.
    van den Bemd GJ; Pols HA; van Leeuwen JP
    Curr Pharm Des; 2000 May; 6(7):717-32. PubMed ID: 10828303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.
    Nolan E; Donepudi M; VanWeelden K; Flanagan L; Welsh J
    Mol Cell Biochem; 1998 Nov; 188(1-2):13-20. PubMed ID: 9823006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.
    Wang Q; Lee D; Sysounthone V; Chandraratna RAS ; Christakos S; Korah R; Wieder R
    Breast Cancer Res Treat; 2001 May; 67(2):157-68. PubMed ID: 11519864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.